is there a patent on semaglutide expires next year: Novo Nordisk faces tough competition in the Chinese obesity market Semaglutide generics flood Indian market

Kostoglou-Athanassiou I, Costa A, Navarra P, Nappi G, Forsling ML, Grossman AB

Discontinuing GLP-1s Before or Early in Pregnancy Tied to Weight Gain, Pregnancy Complications Brooke McCormick Rose McNulty Key Takeaways Discontinuing GLP-1 RAs before or during early pregnancy is linked to increased gestational weight gain and pregnancy complications

A class comparison of medication persistence in people with type 2 diabetes: a retrospective observational study

Liv Wellness RX

With GLP-1 receptor agonists (GLP-1 RAs) , we now have a tool that can accelerate weight loss and glycemic control more effectively than ever before producing 518% body-weight reduction in clinical trials ( Endocrinology Advisor )